Skip to main content

Complications of Intrathecal Drug Delivery

  • Chapter
  • 1396 Accesses

Abstract

Intrathecal pumps are an option that allows patients who suffer from moderate-to-severe pain to have an improvement in quality of life, reduction in pain, improvement in systemic side effects, and change in function. They also are an option for patients who are at the end of life to improve alertness, reduce fatigue and nausea, and improve survival in the cancer population. This has been noted to be both clinically beneficial and cost effective, especially in those patients who are expected to survive longer than 6 months. Unfortunately, despite the many positive attributes of these devices, they are not without risks. The complications can be classified as surgical, device related, or drug related. This chapter focuses on the complications of intrathecal drug delivery and options to assess and reduce risks.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Hassenbusch SJ. Cost modeling for alternate routes of administration of opioids for cancer pain. Oncology (Williston Park). 1999;13:63–7.

    CAS  Google Scholar 

  2. Paice JA, Penn RD, Shott S. Intraspinal morphine for chronic pain: a retrospective, multicenter study. J Pain Symptom Manage. 1996;11:71–80.

    Article  CAS  PubMed  Google Scholar 

  3. Coffey RJ, Burchiel K. Inflammatory mass lesions associated with intrathecal drug infusion catheters: report and observations on 41 patients. Neurosurgery. 2002;50:78–86; discussion 86–7.

    PubMed  Google Scholar 

  4. Staats PS, Yearwood T, Charapata SG, et al. Intrathecal ziconotide in the treatment of refractory pain in patients with cancer and AIDS. JAMA. 2003;291:62–70.

    Google Scholar 

  5. Rathmell JP, Lake TL, Ramundo MB. Infectious risks of chronic pain treatments: injection therapy, surgical implants, and intradiscal techniques. Reg Anesth Pain Med. 2006;31:346–52.

    PubMed  Google Scholar 

Suggested Reading

  • Deer T. A prospective analysis of intrathecal granuloma in chronic pain patients. A review of the literature and report of a surveillance study. An original contribution. Pain Physician. 2004;7:225–8.

    PubMed  Google Scholar 

  • Deer TR, Smith HS, Burton AW, et al. Comprehensive consensus base guidelines on intrathecal drug delivery systems in the treatment of pain caused by cancer pain. Pain Physician. 2011;14:E283–312.

    PubMed  Google Scholar 

  • Deer TR, Smith HS, Cousins M, et al. Consensus guidelines for the selection and implantation of patients with noncancer pain for intrathecal drug delivery. Pain Physician. 2010;13:E175–213.

    PubMed  Google Scholar 

  • Follett KA, Naumann CP. A prospective study of catheter-related complications of intrathecal drug delivery systems. J Pain Symptom Manage. 2000;19:209–15.

    Article  CAS  PubMed  Google Scholar 

  • Harney D, Victor R. Traumatic syrinx after implantation of an intrathecal catheter. Reg Anesth Pain Med. 2004;29:606–9.

    Article  PubMed  Google Scholar 

  • Hayek SM, Deer TR, Pope JE, et al. Intrathecal therapy for cancer and non-cancer pain. Pain Physician. 2011;14:219–48.

    PubMed  Google Scholar 

  • Huntoon MA, Hurdle MF, Marsh RW, Reeves RK. Intrinsic spinal cord catheter placement: implications of new intractable pain in a patient with a spinal cord injury. Anesth Analg. 2004;99:1763–5, table of contents.

    Article  PubMed  Google Scholar 

  • Knight KH, Brand FM, Mchaurab AS, Veneziano G. Implantable intrathecal pumps for chronic pain: highlights and updates. Croat Med J. 2007;48:22–34.

    PubMed Central  PubMed  Google Scholar 

  • Pope JE, Deer TR. Ziconotide: a clinical update and pharmacologic review. Expert Opin Pharmacother. 2013;14:957–66.

    Article  CAS  PubMed  Google Scholar 

  • Thimineur MA, Kravitz E, Vodapally MS. Intrathecal opioid treatment for chronic non-malignant pain: a 3-year prospective study. Pain. 2004;109:242–9.

    Article  CAS  PubMed  Google Scholar 

  • Winkelmuller M, Winkelmuller W. Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology. J Neurosurg. 1996;85:458–67.

    Article  CAS  PubMed  Google Scholar 

  • Yaksh TL, Horais KA, Tozier NA. Chronically infused intrathecal morphine in dogs. Anesthesiology. 2003;99:174–87.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Timothy R. Deer MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media New York

About this chapter

Cite this chapter

Gritsenko, K., Carullo, V., Deer, T.R. (2016). Complications of Intrathecal Drug Delivery. In: Deer, T., Pope, J. (eds) Atlas of Implantable Therapies for Pain Management. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2110-2_43

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-2110-2_43

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-2109-6

  • Online ISBN: 978-1-4939-2110-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics